Tim Wilsdon recently presented at an education forum at ISPOR Latin America, talking about the challenges that gene therapy poses for value assessment and considerations for the future.
For more information about the conference, click here.
Policy action to improve the management of chronic rhinosinusitis with nasal polyps (CRSwNP) in Europe
The objective of this report, commissioned by the BeyondTheNose initiative organised and funded by GSK, was to assess the barriers in the policy environment...